Lymphoma chemotherapy Doctors Abroad — Page 2

Dr. Litleaungdej is a hematologist specializing in lymphoma chemotherapy, trained at Thammasat University Hospital with a focus on blood disorders.

• Completed hematology fellowship at Thammasat University Hospital
• Pioneer hematologist at Huahin Hospital since 2020
• Co-authored research on cancer-associated venous thromboembolism
• Member of Pharmacy and Therapeutics Committee

Dr. Dror Levin is a leading expert in pediatric blood disorders and bone cancer, directing the hematology oncology department at Sourasky Medical Center.

• Specializes in treating bone cancer (sarcoma) in children
• Coordinates treatment with the general Oncology-orthopedic department
• Member of the Israel association for pediatric hemato-oncology (ISPHO)
• Trained in pediatric hematology and oncology at Schneider Children's Medical Center
• Studied oncology bone and soft tissue at Rizzoli Orthopaedic Institute in Italy

34 years of experience of experience in oncohematology – Dr. Aviv specializes in lymphoma chemotherapy at Sourasky Medical Center (Ichilov).

• Focuses exclusively on blood cancers and lymphoma treatments
• Works at one of Israel's leading medical centers
• Provides personalized chemotherapy protocols

Specializes in lymphoma chemotherapy with extensive training at Akdeniz University – one of Turkey's leading medical schools.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at multiple university hospitals including Akdeniz University Hospital
• Currently practices at Medical Park Antalya Hospital Complex

Associate Professor Ali Hakan Kaya specializes in lymphoma chemotherapy and stem cell transplantation, with extensive experience in hematology.

• Subspecialist in hematology and stem cell transplantation
• Expertise in treating Hodgkin and non-Hodgkin lymphomas
• Performs outpatient and inpatient chemotherapies, immunotherapies, and targeted therapies
• Educated at Cerrahpaşa Faculty of Medicine and trained at top hospitals in Turkey

Dr. Herishanu Yair has won multiple awards for his research in chronic lymphocytic leukemia and hematology at Sourasky Medical Center.

• Specializes in hematology with a focus on leukemia treatment
• Received the Young Investigator Research Prize and other distinguished awards
• Member of both the Israeli and American Hematology Associations
• Extensive education including residencies in internal medicine and hematology

Phd Viola Fox leads the Clinic for Haematology, Oncology and Palliative Care at BKZ Solingen – a certified interdisciplinary cancer center.

• Specialized in chemotherapy, immunotherapy, and targeted therapies for lymphoma
• Qualified specialist in genetics with molecular biology research focus
• Member of German and American oncology societies
• Deputy Chief Physician experience in pulmonology and oncology

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Experience in oncology departments across multiple hospitals in Turkey
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Professor Ozkan specializes in lymphoma chemotherapy with 23 years of experience in hematology, currently teaching at Yeditepe University Faculty of Medicine.

• Hematology subspecialist with extensive training in stem cell transplantation
• President of the Turkish Therapeutic Apheresis Association
• Recognized with the Young Researcher Award in 2011
• Member of the European Bone Marrow Transplantation group

Professor of Medical Oncology at Trakya University – Dr. Cicin specializes in lymphoma chemotherapy with 29 years of experience of experience.

• Fellowship-trained in Medical Oncology at Trakya University
• Former Associate Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Mahmoud M El Zembely heads the pediatric oncology department at Shefaa Al Orman Cancer Center. He is a specialist in pediatric oncology and malignant hematology. Dr. El Zembely completed a clinical fellowship in pediatric bone marrow transplantation at the Seattle Cancer Care Alliance. He treats various childhood cancers, including leukemia, lymphoma, and neuroblastoma.

• Manages all types of childhood leukemia and Hodgkin and non-Hodgkin lymphomas.
• Treats solid tumors such as nephroblastoma, rhabdomyosarcoma, and rare childhood cancers.
• Performs allogenic and autologous bone marrow transplantations for pediatric patients.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Leading expert in chronic lymphocytic leukemia – Professor Bosch develops new treatments through over 80 active clinical trials.

• Specializes exclusively in lymphomas and CLL
• Head of Hematology at Vall d'Hebron University Hospital
• Published in NEJM, Nature Medicine, and other top journals
• Conducted groundbreaking research at Columbia University

Dr. Danylesko specializes in lymphoma chemotherapy at Sheba Medical Center, providing personalized treatment plans.

• Experienced in treating various types of lymphoma
• Works with advanced chemotherapy protocols
• Focuses on patient-centric care

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.